2. UroToday Home
  3. Video Lectures

Bladder Cancer Videos

Trimodality Therapy Preserves Bladder in High-Grade T1 Bladder Cancer Patients - Douglas Dahl
November 26, 2024
Details
Muscle-Invasive Bladder Cancer in Non-Curative Patients: A Study on Survival and Palliative Care Needs - Beyond the Abstract
November 21, 2024
Details
Five Things Urologists Need to Know About Bladder and Kidney Cancer in 2025 "Presentation" - Gautam Jayram
November 19, 2024
Details
Occupational and Environmental Factors Linked to Bladder Cancer in High-Risk Groups - Sunil Patel
November 9, 2024
Details
Working Group Addresses Excellence in Community Bladder Cancer Care Delivery - Janet Kukreja
November 8, 2024
Details
36-Month Efficacy of Nadofaragene in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer - Yair Lotan
October 31, 2024
Details
BRAVO Trial Highlights Improved Detection Reduces Bladder Cancer Recurrence - Ali Nasrallah
October 31, 2024
Details
Addressing Cognitive Decline in Bladder Cancer Patients Through Prehab and Rehab - Sarah Psutka
October 25, 2024
Details
LEGEND Trial Investigates EG-70 in Bladder Cancer Patients - Gautier Marcq
October 18, 2024
Details
SWOG Trial On Standard vs Extended Lymphadenectomy in Muscle Invasive Bladder Cancer - Seth Lerner
October 15, 2024
Details
JCOG1019 Trial Examines Watchful Waiting vs BCG for High-Grade T1 Bladder Cancer - Hiroshi Kitamura
October 9, 2024
Details
Variant Histology Bladder Cancer Challenges and Future Directions - Syed Hussain
October 7, 2024
Details
Bladder Cancer Research Explores Fecal Transplants and Nutritional Strategies - Laura Bukavina
October 5, 2024
Details
SunRISe-1 Trial Advances Bladder Cancer Treatment with TAR-200 - Michiel Van der Heijden
September 27, 2024
Details
Bladder Cancer Breakthroughs in SunRISe-1, AMBASSADOR, and VOLGA Trials - Maria De Santis
September 21, 2024
Details
Genetic Profiles in Early vs. Late Stage Urothelial Cancer - Dag Stormoen
September 15, 2024
Details
Harnessing Artificial Intelligence in Bladder Cancer: Digital Tools for Enhanced Diagnosis and Treatment - David McConkey
September 4, 2024
Details
Patient Perspectives on Bladder Cancer: Balancing Treatment Options and Shared Decision-Making - Roger Li
September 4, 2024
Details
Advancing Radiopharmaceuticals: Targeting Strategies and Isotope Selection in Cancer Therapy - John Babich
August 9, 2024
Details
Refined Model Improves Bladder Cancer Risk Stratification - Francesco Soria
August 8, 2024
Details
Novel Therapies for Non-Muscle Invasive Bladder Cancer: Expert Review - Felix Guerrero-Ramos
July 29, 2024
Details
Urban vs Rural Bladder Cancer Mortality: 20-Year Trend Analysis - Jason Brown
July 28, 2024
Details
ctDNA in Non-Muscle Invasive Bladder Cancer: Screening & Prognosis - Saum Ghodoussipour
July 22, 2024
Details
Trimodal Therapy in Urothelial vs Non-Urothelial Bladder Cancer - Mario de Angelis
July 22, 2024
Details
The Best of ASCO 2024 in Advanced Bladder Cancer - Shilpa Gupta
July 3, 2024
Details
Small Cell Neuroendocrine Carcinoma of Urinary Tract: Relapse Factors & Treatment - Omar Alhalabi
July 2, 2024
Details
dMMR and MSI-H in Urothelial Carcinoma: Prevalence and Treatment Implications - Elias Chandran
June 29, 2024
Details
Novel CD40 Antibody Treatment for BCG-Unresponsive Bladder Cancer - Bernard Bochner
June 27, 2024
Details
Robotic vs. Open Radical Cystectomy: 3-Year RCT Results Revealed - Giuseppe Simone
June 26, 2024
Details
Advancing Female Bladder Cancer Care: Insights from AUA's First Specialized Course - Armine Smith
June 25, 2024
Details
Orion Study Evaluates Paclitaxel Conjugate for BCG-Unresponsive Cancer - Sunil Patel
June 24, 2024
Details
Patient Burdens and Openness to In-Home Intravesical Therapy for Bladder Cancer - Timothy Lyon & Amanda Myers
June 24, 2024
Details
Optimizing Next-Generation Sequencing in Urothelial Cancer: Expert Consensus Recommendations - Andrea Necchi
June 22, 2024
Details
MoonRISe-1: Evaluating TAR-210 for Intermediate-Risk Non-Muscle-Invasive Bladder Cancer - Roger Li
June 19, 2024
Details
Bladder-Sparing Chemoradiation for Localized Bladder Cancer: Addressing the Unmet Need - Brent Rose
June 18, 2024
Details
SunRISe-5 Trial: Evaluating TAR-200 for Recurrent High-Risk Non-Muscle Invasive Bladder Cancer - Sima Porten
June 18, 2024
Details
Adequate BCG Therapy for Very High-Risk Non-Muscle-Invasive Bladder Cancer: A Multicenter Analysis - José Daniel Subiela Henriquez
June 17, 2024
Details
Bridging the Gap in Microhematuria Evaluation: A Discussion on the STRATA Trial - Yair Lotan
June 14, 2024
Details
Cretostimogene Grenadenorepvec: A Novel Oncolytic Immunotherapy for BCG-Unresponsive NMIBC - Roger Li
June 12, 2024
Details
CORE-001 Study Demonstrates Promising Results for Bladder Cancer with Cretostimogene Grenadenorepvec and Pembrolizumab - Trinity Bivalacqua & Roger Li
June 6, 2024
Details
Apalutamide for Preventing Bladder Cancer Recurrence: A Proof-of-Principle Trial - Edward Messing
June 5, 2024
Details
Innovative Trials Highlight Progress in Treating Urothelial Carcinoma at AUA 2024 - Karim Chamie
May 24, 2024
Details
KEYNOTE-676 Cohort A: Pembrolizumab + BCG for Previously BCG-Treated NMIBC - Neal Shore
May 23, 2024
Details
AUA 2024 Urothelial Carcinoma Highlights - Woodson Smelser
May 23, 2024
Details
Immunotherapy Advancements in Bladder Cancer: Clinical Trials, Early Intervention, and Toxicity Management - Matt Galsky & Neal Shore
May 21, 2024
Details
SSANTROP Trial: Evaluating Sacituzumab Govitecan and Sasanlimab for BCG-Unresponsive Bladder Cancer - Oscar Rodriguez-Faba
May 20, 2024
Details
Exploring the Complexities of Bladder Cancer Surveillance: Cytology, UroVysion, and Beyond - Komal Pohar & Kelly Bree
May 17, 2024
Details
The Evolving Role of Radical Cystectomy in the Era of Bladder-Sparing Therapies - Sima Porten & Roger Li
May 17, 2024
Details
Balancing Bladder Preservation with Effective Treatment in Cancer Care - Petros Grivas
May 17, 2024
Details
Managing Variant Histology in High-Risk Non-Muscle Invasive Bladder Cancer - Michael Cookson & Paolo Gontero
May 17, 2024
Details
To TURBT or Not to TURBT? Evaluating Treatment Options for Recurrent Low-Grade, Intermediate-Risk Bladder Tumors - Sarah Psutka & Param Mariappan
May 17, 2024
Details
AI-Based Assessment Tool for Predicting BCG Response in Bladder Cancer Patients - Yair Lotan
May 14, 2024
Details
Defining Standard and Extended Pelvic Lymphadenectomy in Bladder Cancer Surgery - Seth Lerner & Siamak Daneshmand
May 15, 2024
Details
Leveraging AI Biomarkers to Navigate the Evolving Landscape of Bladder Cancer Treatment - Stephen Williams
May 15, 2024
Details
Navigating the Expanding Landscape of BCG-Unresponsive NMIBC Treatment Options - Mark Tyson
May 10, 2024
Details
Integrating Nadofaragene Firadenovec into Clinical Practice for Non-Muscle Invasive Bladder Cancer Treatment - Ashish Kamat
May 13, 2024
Details
BOND-003 Trial: Cretostimogene Grenadenorepvec Shows Promise in BCG-Unresponsive NMIBC - Mark Tyson
May 10, 2024
Details
VA BRAVO 2 Study: Blue Light Cystoscopy Improves Outcomes in NMIBC Patients in Equal Access Setting - Stephen B Williams
May 7, 2024
Details
SunRISe-3 Trial: TAR-200 with or without Cetrelimab vs. BCG for BCG-Naive High-Risk NMIBC - Sam Chang
May 6, 2024
Details
Breaking Paradigms: BOND-003's Cretostimogene Monotherapy for High-Risk, BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mark Tyson
May 3, 2024
Details
Racial Differences in Bladder Cancer Detection Using Blue Light Cystoscopy: A Multi-Center Study - Siamak Daneshmand
May 1, 2024
Details
Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer AUA/SUO Guideline - 2024 Amendment - Jeffrey Holzbeierlein
April 29, 2024
Details
Implementing Nadofaragene Firadenovec Treatment in NMIBC - Mark Tyson, Aimee Boden, & Meghann Davis
April 1, 2024
Details
How Long is Recovery After TURBT? Patient-Reported Outcomes Provide Answers - Marshall Strother
March 21, 2024
Details
Clearing the Smoke: Underreporting of Smoking Status in Bladder Cancer Clinical Trials - Hannah Kay & Marc Bjurlin
March 18, 2024
Details
AIM High: Epigenetic Modulation and Immune Stimulation in Bladder Cancer - Elizabeth Koehne
March 15, 2024
Details
Sequential Gemcitabine and Docetaxel Shows Promise for Intermediate-Risk NMIBC - Vignesh Packiam
March 14, 2024
Details
Guidelines Aim to Harmonize and Optimize Urothelial Carcinoma Clinical Trials - Ashish Kamat and Matthew Galsky
March 13, 2024
Details
Intravesical Gemcitabine-Docetaxel Shows Durable Response in Recurrent High-Risk NMIBC After BCG - Mark Preston
March 13, 2024
Details
Age Alone Should Not Preclude BCG Therapy in NMIBC - Ashish Kamat
March 13, 2024
Details
Cretostimogene Grenadenorepvec in BCG-Unresponsive NMIBC: A Discussion on the BOND-003 and CORE1 Trials - Trinity Bivalacqua
March 12, 2024
Details
Understanding BCG Unresponsive NMIBC: Patient Perspectives, Treatment Options, and Clinical Guidance - Gautam Jayram
March 12, 2024
Details
Understanding Risk Stratification in Non-Muscle Invasive Bladder Cancer: Applying AUA Guidelines in Clinical Practice - Neal Shore
March 11, 2024
Details
Impact of Agent Orange Exposure on Non-Muscle Invasive Bladder Cancer Outcomes - Kyle Richards
March 7, 2024
Details
Disparities and Underutilization of Aggressive Therapy in Muscle-Invasive Bladder Cancer: An NCDB Analysis - James Ferguson
March 7, 2024
Details
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma - Arlene Siefker-Radtke
March 6, 2024
Details
Plasmacytoid Variant Bladder Cancer: Aggressive Disease Requiring Multimodal Therapy - Akshay Sood
March 6, 2024
Details
Combining Pembrolizumab and BCG Immunotherapies: The KEYNOTE-676 Trial in High-Risk NMIBC - Neal Shore
March 5, 2024
Details
Intravesical Erdafitinib (TAR-210) Demonstrates High Response Rates in NMIBC With Reduced Toxicity - Roger Li
March 4, 2024
Details
Genetic Overlap Discovered Between Cancerous and Non-Cancerous Bladder Tissue in Small Study - Roger Li
March 4, 2024
Details
ANTICIPATE II Trial: APL-1202 and Tislelizumab for Neoadjuvant Bladder Cancer Treatment - Matthew Galsky
March 4, 2024
Details
Comprehensive Genetic Profiling May Optimize Targeted Therapy Selection for FGFR3-Mutated Urothelial Carcinoma Patients - Michael Basin
March 4, 2024
Details
The Economic Impact of Cystectomy vs Trimodal Bladder Therapy - Stephen Williams
March 1, 2024
Details
BCG Shortage: What’s on the Horizon to Replace? - Joshua Meeks
February 28, 2024
Details
Treatment Options Expand for BCG Unresponsive Bladder Cancer - Mark Tyson
February 22, 2024
Details
PIVOT-006 - A Study of Intravesical Cretostimogene Grenadenorepvec for Treatment of Patients with Intermediate-Risk, Non-Muscle Invasive Bladder Cancer - Mark Tyson
February 13, 2024
Details
Establishing Nadofaragene Firadenovec in a Large Urology Practice - Daniel Canter
February 12, 2024
Details
Real-World Use of Nadofaragene Firadenovec - Siamak Daneshmand
February 7, 2024
Details
The Microbiome's Impact on the Immunotherapy of Genitourinary Cancers - Sumanta Kumar Pal
February 1, 2024
Details
Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-Unresponsive NMIBC - Stephen Boorjian
January 22, 2024
Details
Bladder Cancer: En Bloc Resection Technique Shows Promise - David D'Andrea
January 12, 2024
Details
Contemporary Role of Lymph Node Dissection in Genitourinary Cancers: Where Are We in 2023? - Amanda Myers
January 10, 2024
Details
Chinese Trial Shows Blue Light Cystoscopy Superior for Bladder Cancer Detection - Hongxian Zhang
January 10, 2024
Details
BOND-003 Phase 3 Results: Revolutionizing Bladder Cancer Treatment with Intravesical Cretostimogene Grenadenorepvec Monotherapy for High-Risk BCG-Unresponsive NMIBC - Mark Tyson
January 8, 2024
Details
Exploring Promising Therapies and Genomic Insights in Bladder Cancer Research - Laura Bukavina
January 8, 2024
Details
Bladder Cancer Patients Experience High Burden From Current Intravesical Therapy Model - Amanda Myers
January 4, 2024
Details
Phase 2 Trial: Chemotherapy Plus Immunotherapy Facilitates Bladder Sparing in Muscle-Invasive Bladder Cancer - Matthew Galsky
January 4, 2024
Details
Leaders Establish Consensus Criteria for High-Risk Bladder Cancer Trials, Journal Club - Rashid Sayyid & Zachary Klaassen
December 21, 2023
Details
Exploring Bladder Cancer Innovations: A Deep Dive into ESMO 2023 - Morgan Rouprêt
December 13, 2023
Details
Operationalizing Blue Light in Your Practice - Gautam Jayram
December 12, 2023
Details
Cretostimogene Grenadenorepvec Therapy Aims to Fill an Unmet Need in the Bladder Cancer Armamentarium - Robert Svatek
December 12, 2023
Details
Novel Gene Therapy Shows Efficacy and Tolerable Safety Profile for Patients with Treatment-Resistant Bladder Cancer - Trinity Bivalacqua
November 28, 2023
Details
Successful Bladder Cancer Programs: What Should You Be Offering Your Patients Today and Tomorrow? "Presentation" - Daniel Saltzstein, Jonathan Henderson & Jay Krishnan
November 14, 2023
Details
For Bladder Cancer Patients, New Hope From Immunotherapy Innovations from ESMO 2023 - Petros Grivas
November 14, 2023
Details
Supportive Care in Bladder Cancer: A Deep Dive into Global Patient Needs and the Role of Healthcare Professionals - Bente Jensen & Alex Filicevas
November 3, 2023
Details
Bladder Cancer's Impact on Daily Life and Employment: A Global Perspective - Lydia Makaroff & Lori Funk-Cirefice
October 11, 2023
Details
Quality of Life in Bladder Cancer: A Comparative Study on Cystectomy vs. Bladder Preservation - Vedang Murthy
October 10, 2023
Details
The Global Bladder Cancer Survey: A Strategic Analysis of Diagnosis and Care - Stephanie Demkiw & Lydia Makaroff
October 3, 2023
Details
Global Insights into Bladder Cancer Care: A Comprehensive Survey by the World Bladder Cancer Patient Coalition - Patrick Hensley & Lydia Makaroff
September 27, 2023
Details
Advancing Bladder Cancer Surveillance: The Impact of Flexible Blue Light Cystoscopy from the Nordic Registry - Karsten Zieger
September 6, 2023
Details
New Research Sheds Light on Alternative Treatments for Node-Positive Bladder Cancer - Martin Swinton
September 1, 2023
Details
A New Approach to Bladder Cancer: The ATLAS Trial's Exploration of UGN-102 and TURBT, Journal Club - Rashid Sayyid & Zachary Klaassen
August 25, 2023
Details
A Didactic Lecture on Variant Histology for Urothelial Carcinoma - Charles Guo
August 17, 2023
Details
Comprehensive Geriatric Assessments in Urologic Cancer Care: Identifying Modifiable Risk Factors for Personalized Treatment - Sarah Psutka
August 8, 2023
Details
Device-Assisted Therapies for Bladder Cancer: History, Mechanisms, and Clinical Trials - Wei Shen Tan
August 3, 2023
Details
2023 BCAN Research Innovation Award - Christopher Garris
August 3, 2023
Details
A Novel Mechanism of Tumor Suppression: Unveiling Transcription-Translation Conflict - Andrew Hsieh
August 1, 2023
Details
Tumour Factors and the Variation in Non-Muscle Invasive Bladder Cancer Recurrence After Transurethral Resection Surgery Between Sites: Results from the RESECT Study - Kevin Gallagher
August 1, 2023
Details
Radical Cystectomy vs. Trimodal Therapy: Outcomes in Bladder Cancer - Alexandre Zlotta
July 31, 2023
Details
Extended Node Dissection in Bladder Cancer: SWOG S1011 Trial Insights - Seth Lerner
July 31, 2023
Details
Diversity and Excellence: The Key Criteria in BCAN's Travel Fellowship Selection Process - Max Kates & Petros Grivas
July 28, 2023
Details
Mental Health Illness in Patients with Non-Muscle Invasive Bladder Cancer. Does BCG Play a Role? - Valentina Grajales
July 28, 2023
Details
Expression-Based Subtypes Define Pathologic Response to Neoadjuvant Immune-Checkpoint Inhibitors in Muscle-Invasive Bladder Cancer - Joshua Meeks
July 25, 2023
Details
Reflecting on the 25-Year History of the International Bladder Cancer Network - Peter Goebell
July 6, 2023
Details
NMIBC Molecular Subtypes Predict Differential Response to Intravesical BCG - Tahlita C. M. Zuiverloon
July 5, 2023
Details
Unlocking New Frontiers in Bladder Cancer Treatment with Chemo Ablation and Emerging Technologies - Jørgen Bjerggaard Jensen
June 27, 2023
Details
Probing the Promising Future of Anti-HER2 Therapies for Micropapillary Bladder Cancer - Jeffrey Ross
June 27, 2023
Details
The Potential Influence of Circulating Tumor DNA in Treatment Decisions for Bladder Cancer - Petros Grivas
June 27, 2023
Details
Radical Cystectomy Versus Trimodality Therapy for Muscle-Invasive Bladder Cancer: A Multi-Institutional Propensity Score Matched and Weighted Analysis - Jason Efstathiou & Alexandre Zlotta
June 22, 2023
Details
Exploring Acupuncture's Potential to Mitigate BCG Therapy Side Effects: A Phase I/II Trial - Sarah Psutka
June 15, 2023
Details
Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes - Gottfrid Sjodahl & Fredrik Liedberg
June 13, 2023
Details
Exploring Erdafitinib: A Breakthrough in Non-Muscle Invasive Bladder Cancer Treatment - Siamak Daneshmand
June 12, 2023
Details
Gene Therapy for NMIBC: A New Era of Treatment - Colin Dinney
June 9, 2023
Details
Genomic Heterogeneity as a Barrier to Precision Oncology in Urothelial Cancer - Timothy Clinton
June 9, 2023
Details
Improving Bladder Cancer Treatment: An Insight into Vanderbilt's Innovative BCG Clinic - Meredith Donahue & Tara Cumming
June 8, 2023
Details
Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the BCG Drug Shortage - Brian Chun
June 7, 2023
Details
Unveiling the Promising Role of FAP PET Imaging in Accurate Bladder Cancer Staging - Domenique Escobar
June 6, 2023
Details
Novel Models for Bladder Cancer Progression and Drug Development - John Taylor III
June 5, 2023
Details
When and How To Perform Active Surveillance for Low-risk Non–muscle-invasive Bladder Cancer - Roberto Contieri
June 1, 2023
Details
Agent Orange and Bladder Cancer: Insights from a Study on 25 Million Veterans - Stephen Williams
May 30, 2023
Details
Exploring Tumor Biomarkers in Urothelial Carcinoma: Insights and Advancements in Bladder Cancer Research - Chad Ritch
May 28, 2023
Details
Optimizing Care of Bladder Cancer in Women - Katie Murray
May 28, 2023
Details
Assessing the Effectiveness of N-803 for BCG Unresponsive Bladder Cancer: Promising Complete Remission Rates and Improved Long-Term Response - Patrick Soon-Shiong
May 5, 2023
Details
Combining CG0070 Adenovirus Vector with Immune Checkpoint Blockade: Promising Results for BCG Unresponsive Bladder Cancer Patients - Roger Li
March 29, 2023
Details
Targeting the HLA-E/NKG2A Axis to Overcome BCG Resistance in NMIBC, BCAN Translational Clinical Trial Award - Amir Horowitz
March 29, 2023
Details
The "Get Moving Trial" Home-based Pre and Rehabilitation Intervention for Muscle-invasive Bladder Cancer, BCAN Translational Clinical Trial Award - Sarah Psutka
March 29, 2023
Details
Developing Centers of Excellence for Treatment of Major Urological Cancers in Australia - Manish Patel
March 22, 2023
Details
Gene Expression and Molecular Subtyping in GU Cancers Presentation - Ewan Gibb
March 16, 2023
Details
The SunRISe-4 Trial: A Critical Look at Immunotherapy in Bladder Cancer - Sarah Psutka
March 2, 2023
Details
Fueling Wellness with Flavor for Cancer Patients: The Wellness Principles - Gary Deng
January 30, 2023
Details
A Glimpse into the Future of Bladder Cancer Treatment and Innovative Approaches to Enhanced Patient Care - John Sfakianos
January 27, 2023
Details
Exploring the Prognostic and Predictive Value of ctDNA with Signatera - Adam ElNaggar
January 10, 2023
Details
EAU Guidelines on Thromboprophylaxis in Urological Surgery - Kari Tikkinen
January 4, 2023
Details
Risk of Progression in NIMBC Patients Treated with BCG Overestimated by Updated European Association of Urology (EAU) Prognostic Factor Risk Groups - Niyati Lobo
January 4, 2023
Details
Systemic Treatment Options for MIBC and NMIBC - Arlene Siefker-Radtke
December 14, 2022
Details
From Science to Clinical Utility: Cxbladder Monitor - Bladder Cancer Surveillance for Patients with Urothelial Carcinoma - Tamer Aboushwareb, Neal Shore & Josh Meeks
December 1, 2022
Details
Using Artificial Intelligence (AI) to Identify and Diagnose Bladder Cancer - Hikmat Al-Ahmadie & Olivier Elemento
November 18, 2022
Details
MRI Versus Cystoscopic Staging for Newly Diagnosed Bladder Cancer, The BladderPath Trial - Nicholas James
November 18, 2022
Details
From Science to Clinical Utility: Cxbladder Detect - Bladder Cancer Detection for Patients Who Present with Hematuria - Tamer Aboushwareb, Neal Shore & Josh Meeks
November 21, 2022
Details
Unlocking the Potential of Immunohistochemical Panels in Bladder Cancer Treatment - Patrick Hensley
November 1, 2022
Details
Timing of Radical Cystectomy in BCG Unresponsive Disease - Patrick Hensley
October 17, 2022
Details
A Novel Imaging Modality, FAP Imaging for Patients with Bladder Cancer - Vadim S. Koshkin
October 17, 2022
Details
Women in Urologic Oncology - Anne K. Schuckman
October 17, 2022
Details
Bladder Cancer Highlights - Stephen Williams
October 16, 2022
Details
Bladder Cancer in the Older Adult Population: Special Considerations - Tullika Garg
September 20, 2022
Details
Highlighting 25 Years of the International Bladder Cancer Network (IBCN) - Barton Grossman
September 17, 2022
Details
The Controversy Over Radical Cystectomy for N1 and N2 Bladder Cancer: Experts Weigh In - Brant Inman & Yair Lotan
August 24, 2022
Details
Gender Differences in Bladder Cancer - Lauren Cooley
August 2, 2022
Details
Advances in Treatment Options for BCG Unresponsive CIS and Papillary Non-Muscle Invasive Bladder Cancer - QUILT 3.032 - Sam Chang
July 19, 2022
Details
Management Trends & Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma, the USC Experience - Anirban Mitra
July 4, 2022
Details
Comparative Effectiveness of Neoadjuvant Chemotherapy In Bladder And Upper Urinary Tract Urothelial Carcinoma - Jeffrey Holzbeierlein
July 4, 2022
Details
Preventing Recurrence of Urothelial Carcinoma in Patients with Upper Tract Carcinoma - Aditya Bagrodia
July 4, 2022
Details
Surveillance Guidelines for Low-Grade Ta NMIBC Often Not Followed - Stephen Williams
June 20, 2022
Details
Microbiome Research in Bladder Cancer - Laura Bukavina
May 15, 2022
Details
Realities of Bladder Cancer In Women - Sima Porten, Kristen Scarpato, Svetlana Avulova & Anne Schuckman
May 11, 2022
Details
The Critical Role of Nursing in Bladder Cancer Diagnostics and Treatment - Shievon Smith & Jacqueline Duncan
May 2, 2022
Details
Busting Common Myths Regarding Bladder Preservation for Muscle Invasive Bladder Cancer - Nick James & Ananya Choudhury
April 30, 2022
Details
The CABEM Project and the Power of Teamwork: How Multidisciplinary Collaboration Improved Bladder Cancer Outcomes in Brazil - Fernando Korkes
April 28, 2022
Details
RETAIN Trial: A New Hope for Avoiding Cystectomy in Bladder Cancer - Phillip Abbosh
April 18, 2022
Details
Urethral Recurrence after Radical Cystectomy for Bladder Cancer - Ekaterina Laukhtina
April 14, 2022
Details
The Role of Bladder-Sparing Trimodality Therapy - Sophia Kamran
April 14, 2022
Details
Biological Pathways in Urothelial Carcinoma - Carissa Chu
April 12, 2022
Details
Treating Women with Bladder Cancer and a Community Approach to Navigating a Diagnosis - Jeannie Hoffman-Censits & Elizabeth Guancial
April 12, 2022
Details
'BCG-Exposed' Definition Aims to Improve Bladder Cancer Care - Peter Black
February 11, 2022
Details
Comparative Effectiveness of Radical Cystectomy and Trimodality Therapy for Muscle-Invasive Bladder Cancer – Boris Gershman
February 11, 2022
Details
Research in Biomarkers for Bladder Cancer - The BCAN Young Investigator Awards - Benjamin Miron
February 11, 2022
Details
Quality of Life for Patients Undergoing Radical Cystectomy - Bernard Bochner
February 9, 2022
Details
Role of Blue Light Cystoscopy in Detecting Invasive Bladder Tumor - Sia Daneshmand
February 4, 2022
Details
Perioperative Optimization for Patients Undergoing Radical Cystectomy – Sarah Psutka
February 1, 2022
Details
Mucosal Differences in The Bladder - Molly Ingersoll
February 1, 2022
Details
Translational Research in Bladder Cancer, A BCAN Young Investigator - Phillip Abbosh
January 28, 2022
Details
Bladder Cancer Advocacy Network's (BCAN) Young Investigator Award Program - Elizabeth Plimack
January 28, 2022
Details
Financial Toxicity Among Patients with Bladder Cancer - Deborah Kaye
January 23, 2022
Details
Bladder Cancer: A Practical Guide - Ashish Kamat & Peter Black
January 17, 2022
Details
From Athens to Seattle: A Global Conversation on Urologic Care and the Société Internationale d'Urologie - Petros Grivas & Athanasios Papatsoris
January 6, 2022
Details
How Tech Can Minimize Immune-Related Toxicities in Cancer Patients - Pavlos Msaouel
January 4, 2022
Details
Urologists, You’ll Never Walk Alone! - Gianluca Giannarini
December 27, 2021
Details
Systemic Therapies in Advanced Bladder Cancer - Noah Hahn
December 20, 2021
Details
Management of Small Local Recurrence Low-grade Bladder Tumors with Negative Cytology - Marek Babjuk, Morgan Roupret & Wassim Kassouf
December 16, 2021
Details
New Subtype Discovery May Offer Better Treatment Options for Bladder Cancer Therapy - Dan Theodorescu
December 14, 2021
Details
The World Bladder Cancer Patient Coalition Launches Bladder Cancer Patient Survey
December 1, 2021
Details
Financial Toxicity in Bladder Cancer—A Mixed Methods Study of Two Diverse Patient Populations - Sumeet Bhanvadia
November 7, 2021
Details
The Association of Smoking Status with Recurrence in Patients with Predominantly High-Risk Recurrent NMIBC - Richard Matulewicz
October 1, 2021
Details
Value Based Care in Surveillance of Non-Muscle Invasive Bladder Cancer – Stephen Williams
September 22, 2021
Details
ctDNA Guiding Adjuvant Immunotherapy in Urothelial Carcinoma Journal Club – Christopher Wallis & Zachary Klaassen
September 4, 2021
Details
Immunotherapy Treatments Across the Spectrum of Urothelial Cancer Stages - Bishoy Faltas
August 27, 2021
Details
Bladder-Sparing Treatment Options for Muscle-Invasive Bladder Cancer – Andrea Necchi
July 21, 2021
Details
The Clinical Impact and Molecular Drivers of ‘Secondary’ Muscle-Invasive Bladder Cancer - BCAN New Discoveries Young Investigator Award - Eugene J. Pietzak
July 20, 2021
Details
The Management of Primary Carcinoma of The Urethra - Reza Mehrazin
July 18, 2021
Details
The Role of Radiology and Radiomics in Staging & Risk Stratification of NMIBC - Manjiri Dighe
July 1, 2021
Details
Germline and Somatic Interactions in Bladder Cancer - Bishoy Faltas
June 29, 2021
Details
Sexual Function in Women Undergoing Radical Cystectomy, BCAN New Discoveries Young Investigator Award for Patient-Centered Research - Svetlana Avulova
June 22, 2021
Details
Pembrolizumab in Combination With Gemcitabine and Concurrent Hypofractionated Radiation Therapy As Bladder Sparing Treatment for Muscle-Invasive Bladder Cancer - Arjun Balar
June 10, 2021
Details
A Study to Improve the Diagnosis of Bladder Cancer - BladderPath Study - Jim Catto & Gary Steinberg
June 7, 2021
Details
Update on Urine Markers for Hematuria and Bladder Cancer - Yair Lotan
June 1, 2021
Details
Addressing the BCG Shortage: New Strains and Alternative Treatment Options on the Horizon for Bladder Cancer - Janet Kukreja
May 11, 2021
Details
Cost-Effectiveness Analysis of Pembrolizumab for BCG-Unresponsive Carcinoma in Situ of the Bladder - Stephen Boorjian & Kevin Wymer
May 10, 2021
Details
Molecular Landscape of NMIBC and Risk Factors for Progression A Lecture & Discussion - Eugene Pietzak
April 12, 2021
Details
Circulating Tumor DNA - Guiding Treatment Decisions in Bladder Cancer - Lars Dyrskjøt
January 27, 2021
Details
Advances from 2020 in the Management of Muscle Invasive Non-Metastatic Bladder Cancer - Bernard Bochner
January 26, 2021
Details
EAU Guidelines on Non-Muscle-Invasive Bladder Cancer 2020 Update - Marek Babjuk
December 3, 2020
Details
DNA Based Markers in High-risk Non-Muscle Invasive BCG Unresponsive Bladder Cancer - Alexander Wyatt
November 15, 2020
Details
Pembrolizumab in High-Risk, BCG Unresponsive Non-Muscle Invasive Bladder Cancer - Arjun Balar
October 24, 2020
Details
A Patient Perspective on High-Risk Non-Muscle Invasive BCG Unresponsive Bladder Cancer- Karen Sachse
October 22, 2020
Details
How to Define Treatment Failure After BCG Treatment for Nonmuscle-Invasive Bladder Cancer - Peter Black
October 14, 2020
Details
High-Risk Non Muscle-Invasive BCG Unresponsive Bladder Cancer - Molecular Subtypes - Woonyoung Choi
October 14, 2020
Details
Vicineum for High-Risk Non-Muscle-Invasive BCG Unresponsive Bladder Cancer - Rian J. Dickstein
November 15, 2020
Details
The Role of the PD-L1 Checkpoint in BCG Resistance - Max Kates
November 15, 2020
Details
Variant Histology Urothelial Carcinoma: A Patient Case - Makarand Khochikar
August 26, 2020
Details
T2 N0 M0 High-grade Urothelial Carcinoma Patient Case Study with Cushingoid Features Undergoing Radical Cystectomy in Neobladder - Makarand Khochikar
August 25, 2020
Details
Clinically Node Positive Bladder Cancer and The Timing of Surgery - Neema Navai
August 18, 2020
Details
The Management of Bladder Cancer During Pregnancy - Makarand Khochikar
August 16, 2020
Details
Adherence to Guidelines-Based Management of Non-Muscle Invasive Bladder Cancer Among Society of Urologic Oncology (SUO) Members - Justin T. Matulay
August 4, 2020
Details
Urinary Diversion in Women Following Radical Cystectomy - Renu Eapen
August 4, 2020
Details
Radical Cystectomy and The Importance of Oncological Concepts in Surgical Approach - Rafael Sanchez Salas
August 16, 2020
Details
T2 N0 M0 Muscle-invasive Bladder Cancer Patient Case - Makarand Khochikar
August 15, 2020
Details
Results of the SUO CTC Phase III Nadofaragene Firadenovec Trial for BCG Unresponsive NMIBC - Colin Dinney
July 6, 2020
Details
Blue Light Cystoscopy with Cysview®: Tips and Tricks - Anne Schuckman
June 30, 2020
Details
The RESECT Study: Improving Quality in TURBT Surgery - Veeru Kasivisvanathan
June 30, 2020
Details
AUA Guidelines Case-Based Panel Discussion: Bladder Cancer (Non-muscle and Muscle Invasive) - Joshua Meeks and Sima Porten
June 26, 2020
Details
Macro and Microeconomics of Blue Light Cystoscopy with CYSVIEW® in Non-Muscle Invasive Bladder Cancer - Stephen Williams
June 24, 2020
Details
A Discussion on Implementing the Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer AUA/ASCO/ASTRO/SUO Guidelines - Sam Chang
June 14, 2020
Details
Improving and Optimizing Transurethral Resection of Bladder Tumor (TURBT) Outcomes - Hugh Mostafid
June 10, 2020
Details
Treatment Options for Bacillus Calmette-Guérin (BCG) Refractory Bladder Cancer Disease - Wassim Kassouf
June 7, 2020
Details
Role of Blue Light Cystoscopy in Bladder Cancer Management - Trinity Bivalacqua
May 31, 2020
Details
Bladder Preservation Protocols for Muscle-Invasive Urothelial Carcinoma - Arjun Balar
May 26, 2020
Details
Weathering the Current BCG Shortage Crisis - Michael O’Donnell
May 26, 2020
Details
Blue Light Cystoscopy with Cysview for Management of Non Muscle Invasive Bladder Cancer - Joshua Meeks
May 15, 2020
Details
Implications of the Bacillus Calmette-Guérin (BCG) Shortage - Joshua Meeks
May 12, 2020
Details
Improving Research and Clinical Care, Bladder Cancer in Women - Jean Hoffman-Censits
May 10, 2020
Details
Current and Emerging Therapies for Non-Muscle Invasive Bladder Cancer after BCG - Chris Wallis & Zach Klaassen
April 14, 2020
Details
Phase III Nadofaragene Firadenovec for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Joshua J. Meeks
February 28, 2020
Details
Research and Clinical Practice Strategies Due to the BCG Shortage - Sam S. Chang
February 26, 2020
Details
Bladder Cancer Research That Impacts Urology Clinical Practice - Josh Meeks
February 25, 2020
Details
The Benefits of Early Recovery After Radical Cystectomy (ERAS) Protocols - Sima Porten
February 17, 2020
Details
The BCG Shortage - What To Do In This Setting - Joshua Meeks
January 16, 2020
Details
Advancements in BCG Unresponsive Bladder Cancer: Highlights from the 2019 SUO Meeting - Joshua Meeks
January 16, 2020
Details
A New Era In Systemic Therapies, Pembrolizumab for High Risk Non-Muscle Invasive BCG-Refractory Patients - Arjun Balar
January 8, 2020
Details
Utilizing Change Management for Successful Implementation of Blue light cystoscopy (BLC™) - Rebecca Roe
December 4, 2019
Details
Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy - Badrinath Konety
November 21, 2019
Details
Guided Imagery for Urologic Surgery - Sima Porten
October 31, 2019
Details
Consensus Statement on Flexible Blue Light Cystoscopy (BLC™) with Cysview® - Yair Lotan
October 17, 2019
Details
Comparative Analyses of Costs and Survival Between Radical Cystectomy and Trimodal Therapy - Stephen Williams
September 11, 2019
Details
Blue Light Cystoscopy with CYSVIEW: Improving Detection Rates of Bladder Cancer in the Clinic - Yair Lotan
August 12, 2019
Details
Blue Light Cystoscopy (BLC™): What Urologist Want to Know - Anne Schuckman
August 5, 2019
Details
Toxicity Management with Checkpoint Inhibitor Therapy - Thomas Powles
July 1, 2019
Details
Bladder Cancer in Women - Morgan Roupret
June 17, 2019
Details
BCG Shortage An Update - Jonathan Rubenstein
May 4, 2019
Details
The Role of the Surgeon in the Treatment of Bladder Cancer - Jens Bedke
June 13, 2019
Details
Immunotherapy in the Peri-Operative Setting for Bladder Cancer - Thomas Powles
June 14, 2019
Details
What is New on Bladder Cancer Treatment: ASCO GU 2019? - Josh Meeks
April 18, 2019
Details
ERAS in Bladder Cancer - Sia Daneshmand
April 15, 2019
Details
The State of Immunotherapy in Bladder Cancer - Thomas Powles
April 15, 2019
Details
Bladder Cancer in Women: Improving Diagnosis and Treatment - Jean Hoffman-Censits
April 15, 2019
Details
Optimal Surgical Approaches in Cystectomy - Piyush Agarwal
July 22, 2019
Details
Improving Outcomes in Bladder Cancer - Arnulf Stenzl
June 23, 2019
Details
The Role of the Surgeon in the Management of Metastatic Bladder Cancer - Brant Inman
April 3, 2019
Details
Radical Cystectomy vs Trimodal Therapy for Patients With Localized Muscle-Invasive Bladder Cancer - Stephen B Williams
June 27, 2019
Details
Defining BCG-Unresponsive and The Pathway to Clinical Trials in Treating NMIBC - Ashish Kamat
June 5, 2019
Details
BCG Shortage 2019: Managing Through Treatment and Reimbursement Issues - Neal Shore, Ashish Kamat, and Jonathan Rubenstein
March 4, 2019
Details
2019 BCG Shortage-Perspectives from Josh Meeks
March 1, 2019
Details
Blue Light Cystoscopy with Cysview® in the Surveillance of Bladder Cancer - Sia Daneshmand
February 28, 2019
Details
The Importance of TURBT and the Benefits of Enhanced Cystoscopy - Sima P. Porten
February 1, 2019
Details
Efficacy and Safety of Flexible BLC with Cysview® in the Surveillance of Bladder Cancer - Sia Daneshmand
February 1, 2019
Details
Patient Reported Outcomes in the Use of Blue Light Cystoscopy in the Surveillance of Bladder Cancer - Angela B. Smith
January 25, 2019
Details
Evolution of Technology and Technique in Bladder Cancer - Ashish Kamat
December 10, 2018
Details
Immuno-Oncology in Bladder Cancer: The Urologist's Role - Noah Hahn
November 15, 2018
Details
Is There an Optimal TURBT Technique and the Color War? - Ashish Kamat
November 15, 2018
Details
Keynote-057 Trial for High-Risk Non-Muscle Invasive Bladder Cancer - Evan Yu
November 9, 2018
Details
Is There Still a Role for Chemotherapy in Bladder and Prostate Cancer - Maria De Santis
November 7, 2018
Details
Immunotherapy in Bladder Cancer - Arjun Balar
November 7, 2018
Details
High Grade Non-Muscle Invasive Bladder Cancer and BCG Refractory Patient - Josh Meeks
September 21, 2018
Details
Update on Bladder Cancer, Current Trials and Treatments - Bishoy Faltas
June 24, 2018
Details
CARMENA in mRCC and Surgical Management Cases in Bladder Cancer from ASCO 2018 - Tom Keane
June 23, 2018
Details
Updates in Advanced Urothelial Carcinoma - Highlights from ASCO 2018 - Petros Grivas
June 21, 2018
Details
FDA ALERT: Efficacy Issue Identified in Some Patients Taking Pembrolizumab or Atezolizumab as Monotherapy to Treat Advanced Urothelial Cancer - Petros Grivas
June 21, 2018
Details
Update in Immuno-Oncology in Bladder Cancer - Arjun Balar
June 15, 2018
Details
Journey from Oncologist to Cancer Survivor and Patient Advocate - Burton Needles
May 22, 2018
Details
Setting the Stage for the BCG Unresponsive Population - Interview with Ashish Kamat
May 19, 2018
Details
Helping Patients Cope after Major Interventions for Bladder Cancer Therapy
May 17, 2018
Details
The Changing Landscape in Advanced Bladder Cancer - Tom Keane
April 19, 2018
Details
Advances in Bladder Cancer - Systemic Therapies Including Immunotherapy - Petros Grivas
April 8, 2018
Details
Minimizing Treatment Burden and Biomarkers in Bladder Cancer - Badrinath Konety
April 18, 2018
Details
A Revolutionizing Time in Immuno-Oncology for Bladder Cancer - Neal Shore
March 14, 2018
Details
Enhanced Recovery After Surgery (ERAS) for Radical Cystectomy: History, Rationale and Programmatic Implementation - Thomas Guzzo
February 19, 2018
Details
Treatment Options for Bladder Cancer: Bringing Life to Years of Sparse Options - Guru Sonpavde
January 12, 2018
Details
Enhanced Recovery After Surgery (ERAS) Radical Cystectomy and Urinary Diversion- Ashish Kamat
January 25, 2017
Details